News

Biopharmaceuticals facility for Queensland

Share |

As reported in R&D info: The Federal and Queensland governments have entered an agreement with international drug manufacturer DSM Biologics to operate Australia’s first major contract manufacturing facility for biologic drugs and therapeutics.

The $62 million facility is being built in partnership with Queensland Government-owned BioPharmaceuticals Australia, and will be located with the Translational Research Institute on the Princess Alexandria Hospital campus in Brisbane.

The Queensland Government has provided $7 million in seed funding for the facility under its ten-year Biotechnology Strategic Plan and the Commonwealth is investing $10 million. The remaining $45 million will come from the Translational Research Institute funding pool, which includes $140 million from the Commonwealth and $100 million from the Queensland Government, along with contributions from philanthropic and institutional partners.

The Translational Research Institute, headed by the inventor of Gardasil, Professor Ian Frazer, will open in 2012, with the BioPharmaceuticals Australia facility expected to begin manufacturing by 2013.